Sonoma Pharmaceuticals, Inc. - 8-K Filing
Sonoma Pharmaceuticals held its annual meeting on September 16, 2026 and stockholders approved the election of a Class III director, executive compensation, ratification of auditors, and adjournment proposal. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $SNOA